img

Global Transdermal Preparation Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Transdermal Preparation Market Insights, Forecast to 2034

A transdermal preparation, which may also be considered a Transdermal Drug Delivery System (TDDS), is defined as a flexible, multi-layered, pharmaceutical single dose preparation of varying size containing one or more active substances to be applied to the intact skin for systemic absorption.
Global Transdermal Preparation market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Transdermal Preparation industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Transdermal Preparation key manufacturers include Viatris, ERCO Pharma, MEDRx, Novartis, GSK, 4P Therapeutics, Transdermal Corporation, Medpharm and Nitto, etc. Viatris, ERCO Pharma, MEDRx are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Transdermal Preparation were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Transdermal Preparation market and estimated to attract more attentions from industry insiders and investors.
Transdermal Preparation can be divided into Injectable Preparations and Non Injectable Preparations, etc. Injectable Preparations is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Transdermal Preparation is widely used in various fields, such as Hospital, Clinic and Other,, etc. Hospital provides greatest supports to the Transdermal Preparation industry development. In 2022, global % sales of Transdermal Preparation went into Hospital filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Transdermal Preparation market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Transdermal Preparation market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Viatris
ERCO Pharma
MEDRx
Novartis
GSK
4P Therapeutics
Transdermal Corporation
Medpharm
Nitto
Hunan Jiudian Pharmaceutical
Beijing Tide Pharmaceutical
Luye Pharma Group
Guangzhou Continent Biomedical Technology
Harbin Hexinotai Pharmaceutical Technology
Demo Technology
Novastage Pharmaceuticals (Shenzhen)
Segment by Type
Injectable Preparations
Non Injectable Preparations

Segment by Application


Hospital
Clinic
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Transdermal Preparation plant distribution, commercial date of Transdermal Preparation, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Transdermal Preparation introduction, etc. Transdermal Preparation Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Transdermal Preparation
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Transdermal Preparation Product Introduction
1.2 Market by Type
1.2.1 Global Transdermal Preparation Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Injectable Preparations
1.2.3 Non Injectable Preparations
1.3 Market by Application
1.3.1 Global Transdermal Preparation Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Transdermal Preparation Sales Estimates and Forecasts 2018-2029
2.2 Global Transdermal Preparation Revenue by Region
2.2.1 Global Transdermal Preparation Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Transdermal Preparation Revenue by Region (2018-2024)
2.2.3 Global Transdermal Preparation Revenue by Region (2024-2029)
2.2.4 Global Transdermal Preparation Revenue Market Share by Region (2018-2029)
2.3 Global Transdermal Preparation Sales Estimates and Forecasts 2018-2029
2.4 Global Transdermal Preparation Sales by Region
2.4.1 Global Transdermal Preparation Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Transdermal Preparation Sales by Region (2018-2024)
2.4.3 Global Transdermal Preparation Sales by Region (2024-2029)
2.4.4 Global Transdermal Preparation Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Transdermal Preparation Sales by Manufacturers
3.1.1 Global Transdermal Preparation Sales by Manufacturers (2018-2024)
3.1.2 Global Transdermal Preparation Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Transdermal Preparation in 2022
3.2 Global Transdermal Preparation Revenue by Manufacturers
3.2.1 Global Transdermal Preparation Revenue by Manufacturers (2018-2024)
3.2.2 Global Transdermal Preparation Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Transdermal Preparation Revenue in 2022
3.3 Global Key Players of Transdermal Preparation, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Transdermal Preparation Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Transdermal Preparation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Transdermal Preparation, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Transdermal Preparation, Product Offered and Application
3.8 Global Key Manufacturers of Transdermal Preparation, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Transdermal Preparation Sales by Type
4.1.1 Global Transdermal Preparation Historical Sales by Type (2018-2024)
4.1.2 Global Transdermal Preparation Forecasted Sales by Type (2024-2029)
4.1.3 Global Transdermal Preparation Sales Market Share by Type (2018-2029)
4.2 Global Transdermal Preparation Revenue by Type
4.2.1 Global Transdermal Preparation Historical Revenue by Type (2018-2024)
4.2.2 Global Transdermal Preparation Forecasted Revenue by Type (2024-2029)
4.2.3 Global Transdermal Preparation Revenue Market Share by Type (2018-2029)
4.3 Global Transdermal Preparation Price by Type
4.3.1 Global Transdermal Preparation Price by Type (2018-2024)
4.3.2 Global Transdermal Preparation Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Transdermal Preparation Sales by Application
5.1.1 Global Transdermal Preparation Historical Sales by Application (2018-2024)
5.1.2 Global Transdermal Preparation Forecasted Sales by Application (2024-2029)
5.1.3 Global Transdermal Preparation Sales Market Share by Application (2018-2029)
5.2 Global Transdermal Preparation Revenue by Application
5.2.1 Global Transdermal Preparation Historical Revenue by Application (2018-2024)
5.2.2 Global Transdermal Preparation Forecasted Revenue by Application (2024-2029)
5.2.3 Global Transdermal Preparation Revenue Market Share by Application (2018-2029)
5.3 Global Transdermal Preparation Price by Application
5.3.1 Global Transdermal Preparation Price by Application (2018-2024)
5.3.2 Global Transdermal Preparation Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Transdermal Preparation Market Size by Type
6.1.1 US & Canada Transdermal Preparation Sales by Type (2018-2029)
6.1.2 US & Canada Transdermal Preparation Revenue by Type (2018-2029)
6.2 US & Canada Transdermal Preparation Market Size by Application
6.2.1 US & Canada Transdermal Preparation Sales by Application (2018-2029)
6.2.2 US & Canada Transdermal Preparation Revenue by Application (2018-2029)
6.3 US & Canada Transdermal Preparation Market Size by Country
6.3.1 US & Canada Transdermal Preparation Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Transdermal Preparation Sales by Country (2018-2029)
6.3.3 US & Canada Transdermal Preparation Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Transdermal Preparation Market Size by Type
7.1.1 Europe Transdermal Preparation Sales by Type (2018-2029)
7.1.2 Europe Transdermal Preparation Revenue by Type (2018-2029)
7.2 Europe Transdermal Preparation Market Size by Application
7.2.1 Europe Transdermal Preparation Sales by Application (2018-2029)
7.2.2 Europe Transdermal Preparation Revenue by Application (2018-2029)
7.3 Europe Transdermal Preparation Market Size by Country
7.3.1 Europe Transdermal Preparation Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Transdermal Preparation Sales by Country (2018-2029)
7.3.3 Europe Transdermal Preparation Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Transdermal Preparation Market Size
8.1.1 China Transdermal Preparation Sales (2018-2029)
8.1.2 China Transdermal Preparation Revenue (2018-2029)
8.2 China Transdermal Preparation Market Size by Application
8.2.1 China Transdermal Preparation Sales by Application (2018-2029)
8.2.2 China Transdermal Preparation Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Transdermal Preparation Market Size by Type
9.1.1 Asia Transdermal Preparation Sales by Type (2018-2029)
9.1.2 Asia Transdermal Preparation Revenue by Type (2018-2029)
9.2 Asia Transdermal Preparation Market Size by Application
9.2.1 Asia Transdermal Preparation Sales by Application (2018-2029)
9.2.2 Asia Transdermal Preparation Revenue by Application (2018-2029)
9.3 Asia Transdermal Preparation Sales by Region
9.3.1 Asia Transdermal Preparation Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Transdermal Preparation Revenue by Region (2018-2029)
9.3.3 Asia Transdermal Preparation Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Transdermal Preparation Market Size by Type
10.1.1 Middle East, Africa and Latin America Transdermal Preparation Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Transdermal Preparation Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Transdermal Preparation Market Size by Application
10.2.1 Middle East, Africa and Latin America Transdermal Preparation Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Transdermal Preparation Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Transdermal Preparation Sales by Country
10.3.1 Middle East, Africa and Latin America Transdermal Preparation Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Transdermal Preparation Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Transdermal Preparation Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Viatris
11.1.1 Viatris Company Information
11.1.2 Viatris Overview
11.1.3 Viatris Transdermal Preparation Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Viatris Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Viatris Recent Developments
11.2 ERCO Pharma
11.2.1 ERCO Pharma Company Information
11.2.2 ERCO Pharma Overview
11.2.3 ERCO Pharma Transdermal Preparation Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 ERCO Pharma Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 ERCO Pharma Recent Developments
11.3 MEDRx
11.3.1 MEDRx Company Information
11.3.2 MEDRx Overview
11.3.3 MEDRx Transdermal Preparation Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 MEDRx Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 MEDRx Recent Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Overview
11.4.3 Novartis Transdermal Preparation Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Novartis Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Recent Developments
11.5 GSK
11.5.1 GSK Company Information
11.5.2 GSK Overview
11.5.3 GSK Transdermal Preparation Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 GSK Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GSK Recent Developments
11.6 4P Therapeutics
11.6.1 4P Therapeutics Company Information
11.6.2 4P Therapeutics Overview
11.6.3 4P Therapeutics Transdermal Preparation Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 4P Therapeutics Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 4P Therapeutics Recent Developments
11.7 Transdermal Corporation
11.7.1 Transdermal Corporation Company Information
11.7.2 Transdermal Corporation Overview
11.7.3 Transdermal Corporation Transdermal Preparation Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Transdermal Corporation Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Transdermal Corporation Recent Developments
11.8 Medpharm
11.8.1 Medpharm Company Information
11.8.2 Medpharm Overview
11.8.3 Medpharm Transdermal Preparation Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Medpharm Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Medpharm Recent Developments
11.9 Nitto
11.9.1 Nitto Company Information
11.9.2 Nitto Overview
11.9.3 Nitto Transdermal Preparation Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Nitto Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Nitto Recent Developments
11.10 Hunan Jiudian Pharmaceutical
11.10.1 Hunan Jiudian Pharmaceutical Company Information
11.10.2 Hunan Jiudian Pharmaceutical Overview
11.10.3 Hunan Jiudian Pharmaceutical Transdermal Preparation Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Hunan Jiudian Pharmaceutical Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Hunan Jiudian Pharmaceutical Recent Developments
11.11 Beijing Tide Pharmaceutical
11.11.1 Beijing Tide Pharmaceutical Company Information
11.11.2 Beijing Tide Pharmaceutical Overview
11.11.3 Beijing Tide Pharmaceutical Transdermal Preparation Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Beijing Tide Pharmaceutical Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Beijing Tide Pharmaceutical Recent Developments
11.12 Luye Pharma Group
11.12.1 Luye Pharma Group Company Information
11.12.2 Luye Pharma Group Overview
11.12.3 Luye Pharma Group Transdermal Preparation Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Luye Pharma Group Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Luye Pharma Group Recent Developments
11.13 Guangzhou Continent Biomedical Technology
11.13.1 Guangzhou Continent Biomedical Technology Company Information
11.13.2 Guangzhou Continent Biomedical Technology Overview
11.13.3 Guangzhou Continent Biomedical Technology Transdermal Preparation Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Guangzhou Continent Biomedical Technology Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Guangzhou Continent Biomedical Technology Recent Developments
11.14 Harbin Hexinotai Pharmaceutical Technology
11.14.1 Harbin Hexinotai Pharmaceutical Technology Company Information
11.14.2 Harbin Hexinotai Pharmaceutical Technology Overview
11.14.3 Harbin Hexinotai Pharmaceutical Technology Transdermal Preparation Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Harbin Hexinotai Pharmaceutical Technology Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Harbin Hexinotai Pharmaceutical Technology Recent Developments
11.15 Demo Technology
11.15.1 Demo Technology Company Information
11.15.2 Demo Technology Overview
11.15.3 Demo Technology Transdermal Preparation Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Demo Technology Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Demo Technology Recent Developments
11.16 Novastage Pharmaceuticals (Shenzhen)
11.16.1 Novastage Pharmaceuticals (Shenzhen) Company Information
11.16.2 Novastage Pharmaceuticals (Shenzhen) Overview
11.16.3 Novastage Pharmaceuticals (Shenzhen) Transdermal Preparation Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Novastage Pharmaceuticals (Shenzhen) Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Novastage Pharmaceuticals (Shenzhen) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Transdermal Preparation Industry Chain Analysis
12.2 Transdermal Preparation Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Transdermal Preparation Production Mode & Process
12.4 Transdermal Preparation Sales and Marketing
12.4.1 Transdermal Preparation Sales Channels
12.4.2 Transdermal Preparation Distributors
12.5 Transdermal Preparation Customers
13 Market Dynamics
13.1 Transdermal Preparation Industry Trends
13.2 Transdermal Preparation Market Drivers
13.3 Transdermal Preparation Market Challenges
13.4 Transdermal Preparation Market Restraints
14 Key Findings in The Global Transdermal Preparation Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Transdermal Preparation Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Injectable Preparations
Table 3. Major Manufacturers of Non Injectable Preparations
Table 4. Global Transdermal Preparation Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Transdermal Preparation Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Transdermal Preparation Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Transdermal Preparation Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Transdermal Preparation Revenue Market Share by Region (2018-2024)
Table 9. Global Transdermal Preparation Revenue Market Share by Region (2024-2029)
Table 10. Global Transdermal Preparation Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Transdermal Preparation Sales by Region (2018-2024) & (K Units)
Table 12. Global Transdermal Preparation Sales by Region (2024-2029) & (K Units)
Table 13. Global Transdermal Preparation Sales Market Share by Region (2018-2024)
Table 14. Global Transdermal Preparation Sales Market Share by Region (2024-2029)
Table 15. Global Transdermal Preparation Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Transdermal Preparation Sales Share by Manufacturers (2018-2024)
Table 17. Global Transdermal Preparation Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Transdermal Preparation Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Transdermal Preparation, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Transdermal Preparation Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Transdermal Preparation Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Transdermal Preparation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Preparation as of 2022)
Table 23. Global Key Manufacturers of Transdermal Preparation, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Transdermal Preparation, Product Offered and Application
Table 25. Global Key Manufacturers of Transdermal Preparation, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Transdermal Preparation Sales by Type (2018-2024) & (K Units)
Table 28. Global Transdermal Preparation Sales by Type (2024-2029) & (K Units)
Table 29. Global Transdermal Preparation Sales Share by Type (2018-2024)
Table 30. Global Transdermal Preparation Sales Share by Type (2024-2029)
Table 31. Global Transdermal Preparation Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Transdermal Preparation Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Transdermal Preparation Revenue Share by Type (2018-2024)
Table 34. Global Transdermal Preparation Revenue Share by Type (2024-2029)
Table 35. Transdermal Preparation Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Transdermal Preparation Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Transdermal Preparation Sales by Application (2018-2024) & (K Units)
Table 38. Global Transdermal Preparation Sales by Application (2024-2029) & (K Units)
Table 39. Global Transdermal Preparation Sales Share by Application (2018-2024)
Table 40. Global Transdermal Preparation Sales Share by Application (2024-2029)
Table 41. Global Transdermal Preparation Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Transdermal Preparation Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Transdermal Preparation Revenue Share by Application (2018-2024)
Table 44. Global Transdermal Preparation Revenue Share by Application (2024-2029)
Table 45. Transdermal Preparation Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Transdermal Preparation Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Transdermal Preparation Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Transdermal Preparation Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Transdermal Preparation Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Transdermal Preparation Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Transdermal Preparation Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Transdermal Preparation Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Transdermal Preparation Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Transdermal Preparation Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Transdermal Preparation Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Transdermal Preparation Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Transdermal Preparation Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Transdermal Preparation Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Transdermal Preparation Sales by Country (2024-2029) & (K Units)
Table 60. Europe Transdermal Preparation Sales by Type (2018-2024) & (K Units)
Table 61. Europe Transdermal Preparation Sales by Type (2024-2029) & (K Units)
Table 62. Europe Transdermal Preparation Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Transdermal Preparation Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Transdermal Preparation Sales by Application (2018-2024) & (K Units)
Table 65. Europe Transdermal Preparation Sales by Application (2024-2029) & (K Units)
Table 66. Europe Transdermal Preparation Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Transdermal Preparation Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Transdermal Preparation Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Transdermal Preparation Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Transdermal Preparation Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Transdermal Preparation Sales by Country (2018-2024) & (K Units)
Table 72. Europe Transdermal Preparation Sales by Country (2024-2029) & (K Units)
Table 73. China Transdermal Preparation Sales by Type (2018-2024) & (K Units)
Table 74. China Transdermal Preparation Sales by Type (2024-2029) & (K Units)
Table 75. China Transdermal Preparation Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Transdermal Preparation Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Transdermal Preparation Sales by Application (2018-2024) & (K Units)
Table 78. China Transdermal Preparation Sales by Application (2024-2029) & (K Units)
Table 79. China Transdermal Preparation Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Transdermal Preparation Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Transdermal Preparation Sales by Type (2018-2024) & (K Units)
Table 82. Asia Transdermal Preparation Sales by Type (2024-2029) & (K Units)
Table 83. Asia Transdermal Preparation Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Transdermal Preparation Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Transdermal Preparation Sales by Application (2018-2024) & (K Units)
Table 86. Asia Transdermal Preparation Sales by Application (2024-2029) & (K Units)
Table 87. Asia Transdermal Preparation Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Transdermal Preparation Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Transdermal Preparation Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Transdermal Preparation Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Transdermal Preparation Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Transdermal Preparation Sales by Region (2018-2024) & (K Units)
Table 93. Asia Transdermal Preparation Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Transdermal Preparation Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Transdermal Preparation Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Transdermal Preparation Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Transdermal Preparation Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Transdermal Preparation Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Transdermal Preparation Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Transdermal Preparation Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Transdermal Preparation Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Transdermal Preparation Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Transdermal Preparation Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Transdermal Preparation Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Transdermal Preparation Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Transdermal Preparation Sales by Country (2024-2029) & (K Units)
Table 107. Viatris Company Information
Table 108. Viatris Description and Major Businesses
Table 109. Viatris Transdermal Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Viatris Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Viatris Recent Developments
Table 112. ERCO Pharma Company Information
Table 113. ERCO Pharma Description and Major Businesses
Table 114. ERCO Pharma Transdermal Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. ERCO Pharma Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. ERCO Pharma Recent Developments
Table 117. MEDRx Company Information
Table 118. MEDRx Description and Major Businesses
Table 119. MEDRx Transdermal Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. MEDRx Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. MEDRx Recent Developments
Table 122. Novartis Company Information
Table 123. Novartis Description and Major Businesses
Table 124. Novartis Transdermal Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Novartis Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Novartis Recent Developments
Table 127. GSK Company Information
Table 128. GSK Description and Major Businesses
Table 129. GSK Transdermal Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. GSK Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. GSK Recent Developments
Table 132. 4P Therapeutics Company Information
Table 133. 4P Therapeutics Description and Major Businesses
Table 134. 4P Therapeutics Transdermal Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. 4P Therapeutics Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. 4P Therapeutics Recent Developments
Table 137. Transdermal Corporation Company Information
Table 138. Transdermal Corporation Description and Major Businesses
Table 139. Transdermal Corporation Transdermal Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Transdermal Corporation Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Transdermal Corporation Recent Developments
Table 142. Medpharm Company Information
Table 143. Medpharm Description and Major Businesses
Table 144. Medpharm Transdermal Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Medpharm Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Medpharm Recent Developments
Table 147. Nitto Company Information
Table 148. Nitto Description and Major Businesses
Table 149. Nitto Transdermal Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Nitto Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Nitto Recent Developments
Table 152. Hunan Jiudian Pharmaceutical Company Information
Table 153. Hunan Jiudian Pharmaceutical Description and Major Businesses
Table 154. Hunan Jiudian Pharmaceutical Transdermal Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Hunan Jiudian Pharmaceutical Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Hunan Jiudian Pharmaceutical Recent Developments
Table 157. Beijing Tide Pharmaceutical Company Information
Table 158. Beijing Tide Pharmaceutical Description and Major Businesses
Table 159. Beijing Tide Pharmaceutical Transdermal Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Beijing Tide Pharmaceutical Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Beijing Tide Pharmaceutical Recent Developments
Table 162. Luye Pharma Group Company Information
Table 163. Luye Pharma Group Description and Major Businesses
Table 164. Luye Pharma Group Transdermal Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Luye Pharma Group Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Luye Pharma Group Recent Developments
Table 167. Guangzhou Continent Biomedical Technology Company Information
Table 168. Guangzhou Continent Biomedical Technology Description and Major Businesses
Table 169. Guangzhou Continent Biomedical Technology Transdermal Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Guangzhou Continent Biomedical Technology Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Guangzhou Continent Biomedical Technology Recent Developments
Table 172. Harbin Hexinotai Pharmaceutical Technology Company Information
Table 173. Harbin Hexinotai Pharmaceutical Technology Description and Major Businesses
Table 174. Harbin Hexinotai Pharmaceutical Technology Transdermal Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Harbin Hexinotai Pharmaceutical Technology Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Harbin Hexinotai Pharmaceutical Technology Recent Developments
Table 177. Demo Technology Company Information
Table 178. Demo Technology Description and Major Businesses
Table 179. Demo Technology Transdermal Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Demo Technology Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Demo Technology Recent Developments
Table 182. Novastage Pharmaceuticals (Shenzhen) Company Information
Table 183. Novastage Pharmaceuticals (Shenzhen) Description and Major Businesses
Table 184. Novastage Pharmaceuticals (Shenzhen) Transdermal Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 185. Novastage Pharmaceuticals (Shenzhen) Transdermal Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Novastage Pharmaceuticals (Shenzhen) Recent Developments
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Transdermal Preparation Distributors List
Table 190. Transdermal Preparation Customers List
Table 191. Transdermal Preparation Market Trends
Table 192. Transdermal Preparation Market Drivers
Table 193. Transdermal Preparation Market Challenges
Table 194. Transdermal Preparation Market Restraints
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Transdermal Preparation Product Picture
Figure 2. Global Transdermal Preparation Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Transdermal Preparation Market Share by Type in 2022 & 2029
Figure 4. Injectable Preparations Product Picture
Figure 5. Non Injectable Preparations Product Picture
Figure 6. Global Transdermal Preparation Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Transdermal Preparation Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Transdermal Preparation Report Years Considered
Figure 12. Global Transdermal Preparation Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Transdermal Preparation Revenue 2018-2029 (US$ Million)
Figure 14. Global Transdermal Preparation Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Transdermal Preparation Revenue Market Share by Region (2018-2029)
Figure 16. Global Transdermal Preparation Sales 2018-2029 ((K Units)
Figure 17. Global Transdermal Preparation Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Transdermal Preparation Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Transdermal Preparation Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Transdermal Preparation Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Transdermal Preparation Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Transdermal Preparation Sales YoY (2018-2029) & (K Units)
Figure 23. China Transdermal Preparation Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Transdermal Preparation Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Transdermal Preparation Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Transdermal Preparation Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Transdermal Preparation Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Transdermal Preparation Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Transdermal Preparation in the World: Market Share by Transdermal Preparation Revenue in 2022
Figure 30. Global Transdermal Preparation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Transdermal Preparation Sales Market Share by Type (2018-2029)
Figure 32. Global Transdermal Preparation Revenue Market Share by Type (2018-2029)
Figure 33. Global Transdermal Preparation Sales Market Share by Application (2018-2029)
Figure 34. Global Transdermal Preparation Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Transdermal Preparation Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Transdermal Preparation Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Transdermal Preparation Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Transdermal Preparation Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Transdermal Preparation Revenue Share by Country (2018-2029)
Figure 40. US & Canada Transdermal Preparation Sales Share by Country (2018-2029)
Figure 41. U.S. Transdermal Preparation Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Transdermal Preparation Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Transdermal Preparation Sales Market Share by Type (2018-2029)
Figure 44. Europe Transdermal Preparation Revenue Market Share by Type (2018-2029)
Figure 45. Europe Transdermal Preparation Sales Market Share by Application (2018-2029)
Figure 46. Europe Transdermal Preparation Revenue Market Share by Application (2018-2029)
Figure 47. Europe Transdermal Preparation Revenue Share by Country (2018-2029)
Figure 48. Europe Transdermal Preparation Sales Share by Country (2018-2029)
Figure 49. Germany Transdermal Preparation Revenue (2018-2029) & (US$ Million)
Figure 50. France Transdermal Preparation Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Transdermal Preparation Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Transdermal Preparation Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Transdermal Preparation Revenue (2018-2029) & (US$ Million)
Figure 54. China Transdermal Preparation Sales Market Share by Type (2018-2029)
Figure 55. China Transdermal Preparation Revenue Market Share by Type (2018-2029)
Figure 56. China Transdermal Preparation Sales Market Share by Application (2018-2029)
Figure 57. China Transdermal Preparation Revenue Market Share by Application (2018-2029)
Figure 58. Asia Transdermal Preparation Sales Market Share by Type (2018-2029)
Figure 59. Asia Transdermal Preparation Revenue Market Share by Type (2018-2029)
Figure 60. Asia Transdermal Preparation Sales Market Share by Application (2018-2029)
Figure 61. Asia Transdermal Preparation Revenue Market Share by Application (2018-2029)
Figure 62. Asia Transdermal Preparation Revenue Share by Region (2018-2029)
Figure 63. Asia Transdermal Preparation Sales Share by Region (2018-2029)
Figure 64. Japan Transdermal Preparation Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Transdermal Preparation Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Transdermal Preparation Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Transdermal Preparation Revenue (2018-2029) & (US$ Million)
Figure 68. India Transdermal Preparation Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Transdermal Preparation Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Transdermal Preparation Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Transdermal Preparation Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Transdermal Preparation Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Transdermal Preparation Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Transdermal Preparation Sales Share by Country (2018-2029)
Figure 75. Brazil Transdermal Preparation Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Transdermal Preparation Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Transdermal Preparation Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Transdermal Preparation Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Transdermal Preparation Revenue (2018-2029) & (US$ Million)
Figure 80. Transdermal Preparation Value Chain
Figure 81. Transdermal Preparation Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed